The Lancet Oncology
The Lancet Oncology:
66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner
Read the full press release here!

Language options are available in the header
66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner
Read the full press release here!
